Mission Pharmacal Company
The recipient of graduate certificates in project design and international marketing, Terrell “Terry” Herring brings nearly 30 years of experience in the pharmaceutical industry to Mission Pharmacal Company through his position as president of commercial operations. Under Terry Herring’s guidance, the company has expanded its product reach to include long-term care providers for residents of nursing homes and assisted living facilities.
Mission launched its long-term care plan in 2014 featuring four proven products designed to enhance the comfort, compliance, and dignity of nursing home patients. In addition to a small calcium and vitamin D supplement, Mission also partnered with a company offering an effervescent tablet for oral consumption which increases bone mass and helps treat osteoporosis.
The other two products come in the form of spray bottles, one of which requires a prescription and is used orally to provide relief from dry mouth. Finally, the company offers a zinc oxide spray which provides relief from incontinence associated dermatitis as well as resulting discomfort, illness, and pressure ulcers. Mission continues to seek out and develop unique long-term care products through partnerships with healthcare professionals.
In addition to serving as president of commercial operations for San Antonio-based Mission Pharmacal Company (“Mission”), Terrell “Terry” Herring is the of Alamo Pharma Services in Doylestown, Pennsylvania. Herring’s duties at Mission revolve around producing pharmaceuticals in full compliance with all US Food and Drug Administration (FDA) Current Good Manufacturing Practices (CGMP).
Concerned with all aspects of drug manufacturing, processing, and packaging, CGMP regulations demand on-site inspections of pharmaceutical facilities and the examination of the methodology and controls that each pharmaceutical facility has in place. The FDA demands CGMP compliance reviews as part of its approval process for all new drug and generic drug marketing applications.
In order to encourage the use of modern technologies and drive industry innovation, CGMP requirements are designed to be somewhat flexible. This flexibility allows each manufacturer to achieve higher quality through continual improvement. As long as manufacturers employ scientifically sound operational principles, they have a great deal of leeway when developing facility processing structure and testing procedures.
As an executive at Mission Pharmacal Company in San Antonio, Texas, Terrell Herring oversees the commercial operations of this third-generation pharmaceutical business. In recent years, Terrell Herring was responsible for getting Mission Pharmacal to produce Uribel for Star Pharmaceuticals, LLC.
Uribel is taken to relieve the aches and pains caused by an infection or medical procedure in the urinary tract. Additionally, it helps to lessen the urge to urinate, in addition to alleviating cramps and spasms. While the product helps to alleviate discomfort in the urinary tract, it is not an antibiotic and therefore is not intended for individuals that have already been diagnosed with a urinary tract infection.
As with any medication, patients prescribed Uribel need to inform their physician of any other medications they are taking at the time, including over-the-counter medication, vitamins, and herbal supplements. Also, it is normal for Uribel to cause urine to turn blue in color. Patients should take the full prescription of Uribel even if symptoms disappear.